Pathological factor analysis between different TGFβ groupings in STAD and GSE184336 showed that TGFβ was associated with poorer pathological staging or grading, suggesting that TGFβ may be an important factor in the poor progression of gastric cancer. The gene discussed is TGFB1; the disease is gastric cancer.